isodel PAA – PMC Isochem as CDMO for PolyAmino Acids
![PMC Isochem as CDMO for PolyAmino Acids](https://www.pharmaexcipients.com/wp-content/uploads/2022/08/CDMO-for-PolyAmino-Acids_pmc-isochem_titelbild.jpg)
See in the following the overview on the usage fields of polyamino acids and the service spectrum of PMC Isochem as CDMO in this area:
Why PolyAmino Acids – PAA
- Functional Excipients
- Biodegradable Polymers
- Drug Delivery & Drug Conjugate
- Alternative to PEG (i.e. polysarcosine)
- Less Immunogenic Choice
- Half-life increase of proteins
A unique Integrated Solution
- Talented & Multidisciplinary R&D team
- Broad network for access cutting-edge technologies
- Integrated NCA supply (Phosgene expert)
- Ring Opening Polymerisation (ROP) technology
- Custom PAA synthesis & tailor-made
- From R&D to commercial supply
PMC Isochem services
- 45 years in large scale Manufacturing under GMP
- RSM, Intermediates, APIs and Excipients
- Analytical Development & QC
- Process development and scale up
- 3 FDA & EU qualified facilities (France)
Preclinical, clinical and commercial batches
- Lean approach to provide faster, better and cost effective solutions
- GMP batches for clinical trials
- Stability studies, process & analytical methods validations, reports…
- Full regulatory support (CMC-DMF Documentation)
![CDMO for PolyAmino Acids_pmc isochem](https://www.pharmaexcipients.com/wp-content/uploads/2022/08/CDMO-for-PolyAmino-Acids_pmc-isochem_Zwischenbild-1024x503.jpg)
Why a PAA based delivery technology?
Growing interest for advanced & new polypeptides backbone
PolyAmino Acids (PAAs) based materials have gained more interest in:
> Drug delivery
> Drug conjugates
PAAs demonstrate remarkable biocompatibility and biodegradability due to the nature of the amino acid monomers building blocks
(click the picture to download the brochure)
Source: pmc isochem brochure “isodel PAA – CDMO for PolyAmino Acids by PMC Isochem”
Do you need more information or a sample of isodol PAA excipients?